Dr. Gerald Diaz @GeraldMD
23.4M 13.8K 7.2K
Board Certified Internal Medicine Hospitalist, GrepMed Editor in Chief 🇵🇭 🇺🇸 - Sign up for an account to like, bookmark and upload images to contribute to our community platform. Follow us on IG: https://www.instagram.com/grepmed/ | Twitter: https://twitter.com/grepmeded/
Contributor Ranks
Latest Searches
15 results
hivaids prevention idsa addiction algorithm buprenorphine mycobacterium opioid prescribing alcohol aud aviumcomplex candida candidiasis capsulatum chagas cmv complex conversion crps
Pain Assessment and Management Initiative (PAMI) - Opioid Prescribing and Equianalgesic Chart - Agents and Dosing #Management
Pain Assessment ... #Pain #Pharmacology ... #Opioid #Opiate ... Equianalgesics #Conversion #Doses ... #Dosing #Table
Pearls for Treatment of Alcohol Use Disorder First-line pharmacotherapies for moderate to severe AUD include naltrexone and
include abdominal pain ... risk for using opiates ... respectively) at the doses ... #UseDisorder #Management ... #Medications #Pharmacology
CA-Bridge Buprenorphine Hospital Quick Start Algorithm - Management of acute opiate withdrawal - Any prescriber
Start Algorithm - Management ... of acute opiate ... If patient is stable ... as first-line treatment ... co-exisiting chronic pain
IDSA Recommendations for Preventing and Treating Chagas Disease (American Trypanosomiasis) in HIV-AIDS Preventing Clinical Disease Indication: Individuals
be considered (doses ... PO in 2 divided doses ... #management #opportunistic ... #infections #HIVAIDS ... #pharmacology
IDSA Recommendations for Treating Isospora belli Infection in HIV-AIDS Treating Isospora belli Infection General Management Considerations: • Fluid
General Management ... increase daily dose ... IDSA #Prevention #Treatment ... #management #opportunistic ... #pharmacology
IDSA Recommendations for Treating Mucosal Candidiasis in HIV-AIDS Oropharyngeal Candidiasis: Initial Episodes (Duration of Therapy: 7–14 days) Preferred
mucoadhesive buccal tablet ... chew, or crush tablet ... #management #opportunistic ... #infections #HIVAIDS ... #pharmacology
IDSA Recommendations for Treating Visceral and Cutaneous Leishmaniasis in HIV-AIDS Treating Visceral Leishmaniasis - Preferred Therapy: •
Achieve a total dose ... Leishmaniasis #Prevention #Treatment ... #management #opportunistic ... #infections #HIVAIDS ... #pharmacology
IDSA Recommendations for Treating Cytomegalovirus Infections in HIV-AIDS Preventing CMV Disease: • CMV end-organ disease is best
effective for treatment ... ) for 1–4 doses ... #management #opportunistic ... #infections #HIVAIDS ... #pharmacology
Complex Regional Pain Syndrome (CRPS) - Treatment Non-Pharmacologic: • Education • Physical & occupational therapy • Psychology
Complex Regional Pain ... Non-Pharmacologic ... alendronate) • Opiates ... Trigger point injections ... #Management
IDSA Recommendations for Treating Treponema pallidum Infections (Syphilis) to Prevent Disease in HIV-AIDS Early Stage (Primary, Secondary,
Treponema pallidum Infections ... consultation to guide management ... IDSA #Prevention #Treatment ... #management #opportunistic ... #pharmacology
empty